Phase 1 Urogenital Diseases Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

Prostate CancerNeoplasmsNeoplasms by Site+7 more

Pathos AI, Inc.252 enrolled18 locationsNCT06785636

Recruiting

Phase 1Phase 2

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Prostate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)Prostatic Neoplasms, Castration-Resistant+3 more

Celcuity Inc54 enrolled13 locationsNCT06190899

Recruiting

Phase 1

Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures

Male Urogenital DiseasesUrologic DiseasesUrethral Stricture+1 more

Wake Forest University Health Sciences10 enrolled2 locationsNCT03258658